Notes to the Condensed Financial Statements
For the period from 1 January 2024 to 30 June
2024
1. Summary of significant accounting
policies
Reporting entity
Sherborne Investors (Guernsey) C
Limited (the "Company") is a closed-ended investment company with
limited liability formed under the Companies (Guernsey) Law, 2008
(as amended). The Company was incorporated and registered in
Guernsey on 25 May 2017. The Company's registered office is 1 Royal
Plaza, Royal Avenue, St Peter Port, Guernsey, Channel Islands, GY1
2HL.
The Company commenced dealings on
the London Stock Exchange's Specialist Fund Segment on 12 July
2017
The Company, via SIGC Midco
Limited ("Midco"), a former wholly owned subsidiary of the Company,
which was dissolved and liquidated in 2023, owned 99.98% of the
capital interest in SIGC, LP (Incorporated) (the "Investment
Partnership"), a former subsidiary of the Company which was also
dissolved and liquidated in 2023 as described further
below.
In 2023, the investment manager of
the Investment Partnership, Sherborne Investors Management
(Guernsey) LLC, advised that following the Company's distribution
of proceeds from its indirect investment in Navient Corporation
("Navient"), it did not intend to seek to recall any funds for
further investment. To effectuate this, the Investment
Partnership's investment manager assigned to the Company the
Investment Partnership's interest in SIGC LLC, as the
constitutional documents of SIGC LLC do not permit the recall of
distributed capital for reinvestment. As a result of this
assignment, the Investment Partnership was dissolved by operation
of its limited partnership agreement.
The "Group" was defined as the
Company and its former subsidiaries, Midco and the Investment
Partnership. Both subsidiaries were established/incorporated
in Guernsey. Midco's and the Investment Partnership's results for
the year were included in the consolidated financial statements up
until their respective liquidations. In the opinion of the
Directors, there is no single ultimate controlling
party.
Basis of preparation
The Company's Condensed unaudited
Financial Statements have been prepared in accordance with
International Financial Reporting Standards ("IFRS") as adopted in
the European Union, which comprise standards and interpretations
approved by the International Accounting Standards Board ("IASB")
and International Accounting Standards and Standing Interpretations
Committee, Interpretations approved by the International Accounting
Standards Committee that remain in effect, together with applicable
legal and regulatory requirements of Guernsey law.
The Condensed unaudited Financial
Statements of the Company have been prepared in accordance with
International Accounting Standard 34, 'Interim Financial Reporting'
("IAS 34") as adopted in the European Union, together with
applicable legal and regulatory requirements of Guernsey
Law.
The Directors of the Company have
taken the exemption in Section 244 of the Companies (Guernsey) Law,
2008 (as amended) and have therefore elected to only prepare
standalone Financial Statements for the period.
These Condensed Financial
Statements have been prepared on the historical cost basis, as
modified by the measurement at fair value of investments. The
accounting policies adopted are consistent with those of the
previous financial year and corresponding interim
period.
Going concern
The Condensed Financial Statements
have been prepared on the going concern basis. The net current
asset position as at 30 June 2024 is £0.6 million. The Directors
have considered the impact to the Company, as well as to Navient
Corporation's ("Navient") and the Company's stock prices, of the
current economic environment, including the current interest rates
and inflationary environment, and have concluded that there is no
impact on the going concern. At 30 June 2024 the Company had a NAV
of £454.7 million. The Company, via its investment in SIGC LLC and
other funds in which the Company is indirectly an investor (the
"Funds"), has sufficient liquid assets to meet expected
costs.
The investment manager of the
Funds, Sherborne Investors Management LP (including affiliates, the
"Investment Manager"), has the full intent and ability to provide
the Company with funds as and if required. After making enquiries
of the Investment Manager and Apex Fund and Corporate Services
(Guernsey) Limited (the "Administrator") and based on the
sufficient cash reserves as at 30 June 2024, the Directors have a
reasonable expectation that the Company has adequate resources to
continue its operational activities for the foreseeable future.
Accordingly, they continue to adopt a going concern basis in
preparing these Condensed Financial Statements.
Critical accounting judgments and key sources of estimation
uncertainty
The preparation of the Company's
Condensed Financial Statements requires management to make
estimates and assumptions that affect the reported amounts of
assets, liabilities and contingencies at the date of the Company's
Condensed Financial Statements and revenue and expenses during the
reported period. Actual results could differ from those
estimated.
i) Critical accounting judgement:
Incentive allocation
As more fully described in Note 9,
until 24 May 2023 when the Investment Partnership was dissolved,
the Special Limited Partner was entitled to receive an incentive
allocation once aggregate distributions to partners of the
Investment Partnership exceed a certain level. After the Investment
Partnership's dissolution, the incentive allocation is incurred at
SIGC LLC on the same economic term as previously incurred at the
Investment Partnership and accounted on the same basis. The basis
of the incentive calculation differs depending on how the
investment in the Selected Target Company ("STC") is ultimately
characterised (i.e., as a Turnaround or Stake Building Investment).
The incentive allocation has been computed on a Stake Building
Investment basis, as it does not meet the criteria of a Turnaround
investment.
ii) Critical accounting judgement:
Consolidation of entities
As described further in Note 5, as
at 30 June 2024 the Company holds a non-controlling interest in
SIGC LLC. Whilst the Company holds a majority interest in SIGC LLC
and holds access to the rewards and benefits, it does not exercise
control over the day-to-day operations, nor does it have the
ability to remove the controlling party. As such, SIGC LLC is not
considered a subsidiary and is not consolidated but held and
measured at fair value through profit or loss.
iii) Source of estimation
uncertainty: Financial assets at fair value through profit or
loss
The Company's investments are
measured at fair value for financial reporting purposes. The fair
value of financial assets is based on the net asset value ("NAV")
of the investment. The main contribution to their NAV is the quoted
closing price of the STC and the Company at 30 June 2024, together
with cash balances. Please see Note 5 for further
details.
Adoption of new and revised standards
(i) New standards adopted as at 1
January 2024:
The following standards are
effective for the first time for the financial period beginning 1
January 2024 and are relevant to the Company's
operations:
· Amendments to IAS 1 - Classification of Liabilities as
Current or Non-Current,
· Amendments to IAS 1 - Non-current Liabilities with
Covenants,
· Amendments to IAS 7 - Statement of Cash Flows,
· Amendments to IFRS 7 - Financial Instruments,
· IFRS
S1 - General Requirements for Disclosure of Sustainability-related
Financial Information,
· IFRS
S2 - Climate-related Disclosures.
The above standards have been
adopted and did not have a material impact on the financial
statements.
(ii) Standards, amendments and interpretations
early adopted by the Company:
There were no standards, amendments and
interpretations early adopted by the Company.
(iii) Standards, amendments and
interpretations in issue but not yet effective:
· Amendments to IAS
21 - Lack of Exchangeability
· IFRS 18 -
Presentation and Disclosure in Financial Statements.
Unless stated otherwise, the
Directors do not consider the adoption of any new and revised
accounting standards and interpretations to have a material impact
as the new standards or amendment are not relevant to the
operations of the Company.
c. Functional currency
Items included in the Condensed
Financial Statements of the Company are measured using the currency
of the primary economic environment in which the entity operates.
The Condensed Financial Statements are presented in Pound Sterling
("£"), which is the Company's functional and presentational
currency.
Transactions in currencies other
than £ are translated at the rate of exchange ruling at the date of
the transaction. Monetary assets and liabilities denominated in
foreign currencies at the date of the Condensed Statement of
Financial Position are retranslated into £ at the rate of exchange
ruling at that date. Exchange differences are reported in the
Condensed Statement of Comprehensive Income.
d. Financial assets at fair value through profit or
loss
Investments, including equity
investments in associates, are designated as fair value through
profit or loss in accordance with IFRS 9 'Financial instruments',
as the Company's business model is to invest in financial assets
with a view to profiting from their total return in the form of
interest and changes in fair value. Under International Accounting
Standard 28 'Investments in Associates', the fund can hold its
investments at fair value through profit or loss rather than as an
associate as the Investment Partnership is a closed-ended
fund.
Investments in voting shares and
derivative contracts are initially recognised at cost and are
subsequently re-measured at fair value, as determined by the
Directors. Unrealised gains or losses arising from the revaluation
of investments in voting shares and derivative contracts are taken
directly to the Condensed Statement of Comprehensive
Income.
The Company's investments are
measured at fair value for financial reporting purposes as
described earlier in Note 1 under critical accounting judgements
and key sources of estimation uncertainty.
In determining fair value in
accordance with IFRS 13 'Fair Value Measurement' ("IFRS 13"),
investments measured and reported at fair value are classified and
disclosed in one of the following categories within the fair value
hierarchy:
Level I - An unadjusted
quoted price for identical assets and liabilities in an active
market provides the most reliable evidence of fair value and is
used to measure fair value whenever available. As required by IFRS
13, the Company will not adjust the quoted price for these
investments, even in situations where it holds a large position,
and a sale could reasonably impact the quoted price.
Level II - Inputs are other
than unadjusted quoted prices in active markets, which are either
directly or indirectly observable as of the reporting date, and
fair value is determined through the use of models or other
valuation methodologies.
Level III - Inputs are
unobservable for the investment and include situations where there
is little, if any, market activity for the investment. The inputs
into the determination of fair value require significant management
judgement or estimation.
The Company's investments are
summarised by Level in Note 5. On disposal of shares, cost of
investments is allocated on a first in, first out basis.
e. Revenue recognition
Investment income and interest
receivable from short-term deposits and Treasury gilts are
recognised on an accruals basis. Where receipt of investment income
is not likely until the maturity or realisation of an investment
then the investment income is accounted for as an increase in the
fair value of the investment.
f. Expenses
All expenses are accounted for on
an accruals basis. Expenses are charged through the Condensed
Statement of Comprehensive Income in the period in which they
occur.
g. Prepaid expenses and trade receivables
Trade and other receivables are
initially recognised at fair value and subsequently, where
necessary, re-measured at amortised cost using the effective
interest method. A provision for impairment of trade receivables is
established when there is objective evidence the Company will not
be able to collect all amounts due according to the original terms
of the receivables. The Company only holds trade receivables with
no financing component and which have maturities of less than 12
months at amortised cost and has therefore applied the simplified
approach to expected credit loss.
h. Cash and cash equivalents
Cash and cash equivalents comprise
cash in hand, call and current balances with banks and similar
institutions, which are readily convertible to known amounts of
cash and which are subject to insignificant risk of changes in
value. This definition is also used for the Condensed Statement of
Cash Flows. The carrying amount of these assets approximate their
fair value, unless otherwise stated.
i. Trade and other payables
Trade and other payables are
initially recognised at fair value and subsequently, where
necessary, re-measured at amortised cost using the effective
interest method.
j. Financial instruments
Financial assets and liabilities
are recognised in the Company's Condensed Statement of Financial
Position when the Company becomes a party to the contractual
provisions of the instrument.
k. Segmental reporting
As the Company invests in one
investee company, there is no segregation between industry,
currency or geographical location and therefore no further
disclosures are required in conjunction with IFRS 8 'Operating
Segments'.
l.
Incentive allocation
Until 24 May 2023 when the
Investment Partnership was dissolved, the incentive allocation was
accounted for on an accruals basis (see also Note 9). After the
Investment Partnership's dissolution, the incentive allocation is
incurred at SIGC LLC on the same economic term as previously
incurred at the Investment Partnership and accounted on the same
basis. Please see note 9 for further details. The incentive
allocation was payable to the non-controlling interest and would
therefore be recognised in the Condensed Statement of Changes in
Equity rather than recognised as an expense in the Condensed
Statement of Comprehensive Income.
m. Change in reporting entity
In the current period, the Company
has transitioned from presenting consolidated financial statements
to unconsolidated financial statements due to the liquidation of
its subsidiaries. This change has been applied retrospectively to
ensure comparability with the current year's financial statements,
in accordance with IFRS 10 and IAS 1.
The financial statements for the
period ended 30 June 2023 and 31 December 2023 have been restated
to reflect the changes as if the entities were not
consolidated.
As per IFRS10, upon the
dissolution of a subsidiary, the parent shall account for all
amounts previously recognised in other comprehensive income in
relation to that subsidiary on the same basis as would be required
if the parent had disposed of the related assets or liabilities. In
December 2023, the Company recognised an amount of £7.6 as
reclassification for transfer of balances directly to retained
reserves relation to the amount that was booked at the Investment
Partnership prior to the dissolution. This is reflected in the
Condensed Statement of Changes in Equity on line item
'Reclassification for transfer of balances'.
2.
Comprehensive income/(loss)
The comprehensive income/(loss) has
been arrived at after charging:
|
1 January 2024
to 30 June 2024
|
1 January 2023
to 30 June 2023
|
1 January 2023 to 31
December 2023
|
|
£
|
£
|
£
|
Directors' fees
|
97,500
|
105,318
|
203,054
|
Auditor's remuneration -
Audit
|
55,000
|
31,000
|
55,000
|
Auditor's remuneration - Interim
review
|
-
|
28,000
|
28,000
|
3. Tax on ordinary activities
The Company has been granted
exemption from income tax in Guernsey under the Income Tax (Exempt
Bodies) (Bailiwick of Guernsey) Ordinance 1989 and is liable to pay
an annual fee (currently £1,600) under the provisions of the
Ordinance. As such it will not be liable to income tax in Guernsey
other than on Guernsey source income (excluding deposit interest on
funds deposited with a Guernsey bank). No withholding tax is
applicable to distributions to Shareholders by the
Company.
The Investment Partnership was not
itself subject to taxation in Guernsey. No withholding tax is
applicable to distributions to partners of the Investment
Partnership.
Income which is wholly derived
from the business operations conducted on behalf of the Investment
Partnership with, and investments made in, persons or companies who
are not resident in Guernsey will not be regarded as Guernsey
source income. Such income will not therefore be liable to
Guernsey tax in the hands of non-Guernsey resident limited
partners.
4. Earnings per share
The calculation of basic and
diluted earnings per share is based on the return on ordinary
activities less total comprehensive income attributable to the
non-controlling interest and on there being 700,000,000 weighted average number of shares in issue
during the period (30 June 2023: 700,000,000 and 31 December 2023:
700,000,000). The earnings per share attributable to shareholders
for the period ended 30 June 2024 amounted to a deficit of 15.43
pence per share (period ended 30 June 2023: 7.48 pence per share
and year ended 31 December 2023: 7.36 pence per share).
Date
|
|
Shares
|
|
Days in
issue
|
|
Weighted Average
Shares
|
30 June
2024
|
|
700,000,000
|
|
181
|
|
700,000,000
|
31
December 2023
|
|
700,000,000
|
|
365
|
|
700,000,000
|
5. Financial assets at fair value through profit or
loss
|
As at 30 June
2024
|
As at 30
June
2023
|
As at 31 December
2023
|
|
£
|
£
|
£
|
Opening fair value
|
565,515,552
|
519,806,267
|
519,806,267
|
Contribution to
investments
|
-
|
-
|
-
|
Distributions from
investments
|
(3,750,000)
|
(3,500,000)
|
(6,500,000)
|
Unrealised gain on financial assets
at fair value through profit or loss
|
(107,634,577)
|
52,737,183
|
52,209,285
|
Closing fair value
|
454,130,975
|
569,043,450
|
565,515,552
|
The following tables summarise by
level within the fair value hierarchy the Company's financial
assets and liabilities at fair value as follows:
|
Level I
|
Level II
|
Level III
|
Total
|
30
June 2024
|
£
|
£
|
£
|
£
|
Financial assets at fair value
through profit and loss
|
-
|
-
|
454,130,975
|
454,130,975
|
|
|
|
|
|
30
June 2023
|
£
|
£
|
£
|
£
|
Financial assets at fair value
through profit and loss
|
-
|
-
|
569,043,450
|
569,043,450
|
|
|
|
|
|
31
December 2023
|
£
|
£
|
£
|
£
|
Financial assets at fair value
through profit and loss
|
-
|
-
|
565,515,552
|
565,515,552
|
As at 30 June 2024, the Company's
investment consists solely of a non-controlling interest in SIGC
LLC which was organised to invest in the STC. With SIGC LLC's
balance sheet being measured at fair value, the NAV of SIGC LLC
provides the best estimate of fair value for the Company's
investment in SIGC LLC. SIGC LLC's investment, via an intermediary,
consisted of its non-controlling interest in Newbury Investors LLC
("Newbury"). Newbury's investment in the STC consisted of both
common stock of Navient and of the Company.
The Investment Manager continually
evaluates the optimal allocation of Newbury's ownership of shares
in Navient versus those of the Company. The Investment Manager may
from time to time buy or sell shares in Navient and the Company to
adjust the allocation. Some of the factors in the allocation
decision include the relative liquidity of the shares of Navient
and the Company, the discount to net asset value at which the
Company's shares trade and various tactical considerations, and
general market conditions. Furthermore, the Level III investments
disclosed in the financial statements are solely comprised of the
Company's non-controlling interest in SIGC LLC. The value of those
investments equated to the Company's maximum exposure to loss from
SIGC LLC and Newbury.
A reconciliation of fair value
measurements in Level III is set out in the following
table:
|
As at 30 June
2024
|
As at 30 June
2023
|
As at 31 December
2023
|
|
£
|
£
|
£
|
Opening fair value
|
565,515,552
|
519,806,267
|
519,806,267
|
Distributions from
investments
|
(3,750,000)
|
(3,500,000)
|
(6,500,000)
|
Unrealised gain/(loss) on financial
assets at fair value through profit or loss
|
(107,634,577)
|
52,737,183
|
52,209,285
|
Closing fair value
|
454,130,975
|
569,043,450
|
565,515,552
|
Capital distributions made during
the period ended 30 June 2024 were made to fund the Company's
dividend payment.
Capital distributions made during
the year ended 31 December 2023 were made to fund the Company's
dividend payment. Capital distributions made during the period
ended 30 June 2023 were made to fund the Company's dividend
payment.
The key unobservable inputs in the
valuation of the Level III investment is the value of SIGC LLC's
indirect non-controlling interests in the underlying intermediaries
which is impacted by the share price of Navient and the
Company.
6. Trade and other payables
|
As at
30 June
2024
|
As at
30 June
2023
|
As at
31 December
2023
|
|
£
|
£
|
£
|
Professional fees payable
|
30,565
|
12,697
|
15,298
|
Administration fees
payable
|
30,025
|
11,440
|
30,025
|
Audit fees payable
|
27,350
|
43,500
|
55,000
|
Other payables
|
4
|
5,645
|
4
|
Total
|
87,944
|
73,282
|
100,327
|
7.
Share capital and share premium
|
As
at 30 June 2024
|
As at 30 June
2023
|
As at 31 December
2023
|
Authorised share capital
|
No.
|
No.
|
No.
|
Ordinary Shares of no par
value
|
Unlimited
|
Unlimited
|
Unlimited
|
Issued and fully paid
|
No.
|
No.
|
No.
|
Ordinary Shares of no par
value
|
700,000,000
|
700,000,000
|
700,000,000
|
8. Net asset value per share attributable to the
Company
|
As at 30 June
2024
|
As at 30 June
2023
|
As at 31 December
2023
|
|
|
|
|
Share premium account
|
£
|
£
|
£
|
Share premium account upon
issue
|
700,000,000
|
700,000,000
|
700,000,000
|
Less: Costs of issue
|
(11,060,597)
|
(11,060,597)
|
(11,060,597)
|
Closing balance
|
688,939,403
|
688,939,403
|
688,939,403
|
|
No. of
Shares
|
Pence per
Share
|
30
June 2024
|
700,000,000
|
64.97
|
30
June 2023
|
700,000,000
|
81.51
|
31 December 2023
|
700,000,000
|
80.90
|
9. Related party transactions
The Investment Partnership and its General
Partner engaged Sherborne Investors Management (Guernsey) LLC to
serve as investment manager until the Investment Partnership's
dissolution as disclosed in Note 1. The Investment Manager was
entitled to receive from the Investment Partnership a monthly
management fee equal to one-twelfth of 1% of the net asset value of
the Investment Partnership, less cash and cash equivalents and
certain other adjustments. During the period ended 30 June 2024,
management fees of £Nil (period ended 30 June 2023: £Nil and year
ended 31 December 2023: £2,087,689) were paid by the Investment
Partnership. No balance was outstanding at the period end (period
ended 30 June 2023: £Nil and year ended 31 December 2023:
£Nil).
The Special Limited Partner
interest was held by Sherborne Investors LP until the Investment
Partnership's dissolution as disclosed in Note 1. The Special
Limited Partner was entitled to receive an incentive allocation
once aggregate distributions to partners of the Investment
Partnership, of which one was the Company, exceeded a certain level
of capital contributions to the Investment Partnership, excluding
amounts contributed attributable to management fees.
For Turnaround investments, the
incentive allocation was computed at 10% of the distributions to
all partners in excess of 110%, increasing to 20% of the
distributions to all partners in excess of 150% and increasing to
25% of the distributions to all partners in excess of 200% of
capital contributions, excluding amounts contributed attributable
to management fees. An investment was considered a Turnaround
investment when a member of the General Partner is appointed
chairman of, or accepts an executive role at, the STC.
If, after acquiring a
shareholding, the share price of the STC rises to a level at which
further investment and the effort of a Turnaround is, in the
Investment Manager's opinion, no longer justified or otherwise no
longer presents a viable Turnaround opportunity, the Investment
Partnership intends to sell (and distribute the proceeds to the
Company) or distribute in kind the holding to the limited partners
(in each case after deductions for any costs and expenses and for
the Investment Partnership's Minimum Capital Requirements and
subject to applicable law and regulation), rather than seeking to
join the Board of Directors or otherwise engage with the STC (a
"Stake Building Investment").
For Stake Building Investments,
the incentive allocation was computed at 20% of net returns on the
investment of the Investment Partnership, such amount to be payable
after each partner in the Investment Partnership has had
distributed to it an amount equal to its aggregate capital
contribution to the Investment Partnership in respect to the Stake
Building Investment (excluding any capital contributions
attributable to management fees). The Special Limited Partner may
waive or defer all or any part of any incentive allocation
otherwise due.
At 30 June 2024, there is no
incentive allocation payable by the Investment Partnership. At 30
June 2023 and 31 December 2023, the incentive allocation was
calculated based on a stake building basis and amounted to
£nil.
Pursuant to its constitutional
documents, the management fee and incentive allocation, incurred at
SIGC LLC are on the same economic terms as incurred at the
Investment Partnership as described above.
During the period ended 30 June
2024, each of the Directors (other than the Chairman) received a
fee payable by the Company at the rate of £35,000 per annum. The
Chairman of the Audit Committee received £5,000 per annum in
addition to such fee. The Chairman received a fee payable by the
Company at the rate of £50,000 per annum. As such fees had not been
increased since the Company's incorporation in 2017, the fees were
increased as from 1 July 2024. The Directors now receive a fee of
£40,000 per annum. The Chairman of the Audit Committee receives an
additional sum of £5,600 per annum and the Chairman now receives
£57,000 per annum.
Individually and collectively, the
Directors of the Company hold no shares of the Company as at
30 June 2024 (30 June
2023: Nil and 31 December 2023: Nil).
Sherborne Investors GP, LLC has
granted to the Company a non-exclusive licence to use the name
"Sherborne Investors" in the UK and the Channel Islands in the
corporate name of the Company and in connection with the conduct of
the Company's business affairs. The Company may not sub-licence or
assign its rights under the Trademark Licence Agreement. Sherborne
Investors GP, LLC receives a fee of £70,000 per annum for the use
of the licenced name.
10. Financial risk factors
The Company's investment objective
is to realise capital growth from investment in the STC, identified
by the Investment Manager, with the aim of generating significant
capital return for Shareholders. Consistent with that objective,
the Company's financial instruments mainly comprise an investment
in a STC. In addition, the Company holds cash and cash equivalents
as well as having trade and other receivables and trade and other
payables that arise directly from its operations.
Liquidity
risk
The Company's cash and cash
equivalents are placed in demand deposits with a range of financial
institutions. The listed investment in the STC could be partially
redeemed relatively quickly (within 3 months) should the Company
need to meet obligations or ongoing expenses as and when they fall
due.
The following table details the
liquidity analysis for financial liabilities at the date of the
Condensed Statement of Financial Position:
As
at 30 June 2024
|
Less than 1
month
|
1 - 12
months
|
Total
|
|
£
|
£
|
£
|
Trade and other payables
|
-
|
87,944
|
87,944
|
|
-
|
87,944
|
87,944
|
As
at 30 June 2023
|
Less than 1
month
|
1 - 12
months
|
Total
|
|
£
|
£
|
£
|
Trade and other payables
|
4,000
|
69,282
|
73,282
|
|
4,000
|
69,282
|
73,282
|
As
at 31 December 2023
|
Less than 1
month
|
1 - 12
months
|
Total
|
|
£
|
£
|
£
|
Trade and other payables
|
4,120
|
96,207
|
100,327
|
|
4,120
|
96,207
|
100,327
|
Credit
risk
The Company is exposed to credit
risk in respect of its cash and cash equivalents, arising from
possible default of the relevant counterparty, with a maximum
exposure equal to the carrying value of those assets. The credit
risk on liquid funds is mitigated through the Company depositing
cash and cash equivalents across several banks. The Company is
exposed to credit risk in respect of its trade receivables and
other receivable balances with a maximum exposure equal to the
carrying value of those assets. The Bank of New York Mellon
currently has a stand-alone credit rating of AA- with Standard
& Poor's (31 December 2023: AA- with Standard & Poor's),
Royal Bank of Scotland International has a stand-alone credit
rating of AA- with Standard & Poor's (31 December 2023: A- with
Standard & Poor's) whilst Barclays Bank PLC has a standalone
credit rating of A+ with Standard & Poor's (31 December 2023:
A+ with Standard & Poor's). The Company considers these ratings
to be acceptable.
Market price
risk
Market price risk arises as a
result of the Company's exposure to the future values of the share
price of the STC, including the share price of Navient and the
Company. It represents the potential loss that the Company may
suffer through investing in the STC.
As at 30 June 2024, the share
price of Navient and the Company were 14.56 US dollars per share
and 47.80 pence per share, respectively, which produced the
Company's NAV of £ 454.8 million. At 30 June 2024 a 10%
increase/decrease in the share prices of Navient and the Company
would increase/decrease the Company's NAV by approximately £ 42.2
million.
Foreign exchange
risk
Foreign currency risk arises as
the value of future transactions, recognised monetary assets and
monetary liabilities denominated in other currencies fluctuate due
to changes in foreign exchange rates. The Investment Manager
monitors the Company's monetary and non-monetary foreign exchange
exposure on a regular basis. The Company has limited direct foreign
exchange risk exposure. SIGC LLC's investment in
the US based STC during the year exposes SIGC LLC to foreign
currency risk, however, as a Company this is considered as part of
market price risk.
Interest rate
risk
The Company is subject to risks
associated with changes in interest rates in respect of interest
earned on its cash and cash equivalents. The Company seeks to
mitigate this risk by monitoring the placement of cash balances on
an ongoing basis in order to maximise the interest rates
obtained.
As at 30 June 2024
|
Interest
bearing
|
|
|
|
Less than
1 month
|
1 month to
3 months
|
3 months
to
1 year
|
Non- interest
bearing
|
Total
|
|
£
|
£
|
£
|
£
|
£
|
Assets
|
|
|
|
|
|
Cash and cash
equivalents
|
674,929
|
-
|
-
|
-
|
674,929
|
Financial assets at fair value
through profit or loss
|
-
|
-
|
-
|
454,130,975
|
454,130,975
|
Prepaid expenses
|
-
|
-
|
-
|
48,982
|
48,982
|
Total Assets
|
674,929
|
-
|
-
|
454,179,957
|
454,854,886
|
Liabilities
|
|
|
|
|
|
Other payables
|
-
|
-
|
-
|
87,944
|
87,944
|
Total Liabilities
|
-
|
-
|
-
|
87,944
|
87,944
|
|
|
|
|
|
| |
As at 30 June 2023
|
Interest
bearing
|
|
|
|
Less than
1 month
|
1 month to
3 months
|
3 months
to
1 year
|
Non- interest
bearing
|
Total
|
|
£
|
£
|
£
|
£
|
£
|
Assets
|
|
|
|
|
|
Cash and cash
equivalents
|
1,552,623
|
-
|
-
|
-
|
1,552,623
|
Financial assets at fair value
through profit or loss
|
-
|
-
|
-
|
570,573,724
|
570,573,724
|
Prepaid expenses
|
-
|
-
|
-
|
50,933
|
50,933
|
Total Assets
|
1,552,623
|
-
|
-
|
570,624,657
|
572,177,280
|
Liabilities
|
|
|
|
|
|
Other payables
|
-
|
-
|
-
|
73,282
|
73,282
|
Total Liabilities
|
-
|
-
|
-
|
149,329
|
149,329
|
|
|
|
|
|
| |
As at 31 December 2023
|
Interest
bearing
|
|
|
|
Less than
1 month
|
1 month to
3
months
|
3 months
to
1 year
|
Non- interest
bearing
|
Total
|
|
£
|
£
|
£
|
£
|
£
|
Assets
|
|
|
|
|
|
Cash and cash
equivalents
|
816,593
|
-
|
-
|
-
|
816,593
|
Financial assets at fair value
through profit or loss
|
-
|
-
|
-
|
565,515,552
|
565,515,552
|
Total Assets
|
816,593
|
-
|
-
|
565,515,552
|
566,332,145
|
Liabilities
|
|
|
|
|
|
Other payables
|
-
|
-
|
-
|
100,327
|
100,327
|
Total Liabilities
|
-
|
-
|
-
|
100,327
|
100,327
|
|
|
|
|
|
|
|
|
|
|
|
| |
As at 30 June 2024, the total
interest sensitivity gap for interest bearing items was a surplus
of £674,929 (30 June 2023: surplus of £1,665,200 and 31 December
2023: surplus of £816,593).
As at 30
June 2024, interest rates reported by the
Bank of England were 5.25% (30 June 2023: 5.0% and 31 December
2023: 5.25%) which would equate to net income of £35,434 (period
ended 30 June 2023: £83,269 and year ended 31 December 2023:
£42,871) per annum if interest bearing assets remained constant. If
interest rates were to fluctuate by 100 basis points (period ended
30 June 2023: 100 basis points and year ended 31 December 2023: 100
basis points), this would have a positive or negative effect of
£6,749 (period ended 30 June 2023 a positive or negative effect of
£16,654 and year ended 31 December 2023: a positive or negative
effect of £8,166) on the Company's annual income.
Capital risk
management
The capital structure of the
Company consists of proceeds raised from the issue of Ordinary
Shares. As at 30 June
2024, the Company is not subject to any
external capital requirement.
The Directors believe that at the
date of the Condensed Statement of Financial Position there were no
other material risks associated with the management of the
Company's capital.
11. Distributions
There were no distributions paid
by the company to non-controlling interests during the period ended
30 June 2024. (period ended 30 June 2023: £103,982 and year ended
31 December 2023: £109,627). On 31 December 2023, the Company paid
a dividend of 1.0 pence per share as follows: 0.5 pence per share,
or £3.5 million was paid, on 26 May 2023 to shareholders on the
register at 5 May 2023 and 0.5 pence per share, or £3.5million, was
paid on 6 October 2023 to shareholders on the register at 15
September 2023.
12. Subsequent events
The Company has declared a
dividend of 0.5 pence per share, payable on 4 October 2024 to
shareholders on the register at 13 September 2024.
There were no other material
subsequent events that require disclosure in the condensed
financial statements.